« Back
Home /
Vutrisiran

Vutrisiran

Item no.	HY-132589-10mg
Manufacturer	MedChem Express
CASRN	1867157-35-4
Amount	10 mg
Quantity options	10 mg 1 ea 1 mg 5 mg
Category	Reagents & Chemicals Biochemicals
Type	Chemicals
Specific against	other
Purity	97.37
Citations	[1]Bahru A Habtemariam, et al. Single-Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N-acetylgalactosamine-Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects. Clin Pharmacol Ther. 2021 Feb;109(2):372-382.
Smiles	[Vutrisiran]
ECLASS 10.1	32160000
ECLASS 11.0	32160000
UNSPSC	12000000
Alias	ALN-TTRsc02
Shipping Condition	Room temperature
Available
Manufacturer - Type	Oligonucleotides
Manufacturer - Applications	Neuroscience-Neuromodulation
Manufacturer - Targets	Small Interfering RNA (siRNA); Transthyretin (TTR)
Shipping Temperature	Room Temperature
Storage Conditions	4°C (Powder, sealed storage, away from moisture)
Molecular Weight	16345 (1mg=61nmol; 5mg=306nmol)
Product Description	Vutrisiran (ALN-TTRsc02) is a liver-directed, investigational, small interfering ribonucleic acid (siRNA) agent. Vutrisiran can be used for transthyretin (TTR)-mediated amyloidosis research[1].
Manufacturer - Research Area	Neurological Disease
Solubility	H2O: ≥ 20 mg/mL
Manufacturer - Pathway	Epigenetics; Neuronal Signaling
Clinical information	Launched

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-132589-10mg-safety-datasheet.pdf